Welcome to our dedicated page for Sabra Healthcare REIT news (Ticker: SBRA), a resource for investors and traders seeking the latest updates and insights on Sabra Healthcare REIT stock.
Sabra Healthcare REIT, Inc. (SBRA) is a self-administered and self-managed real estate investment trust (REIT) based in Maryland. Specializing in healthcare properties, Sabra generates revenue by leasing its properties to local, regional, and national healthcare operators and tenants throughout the United States. The company's portfolio is diversified across various segments of the healthcare industry, including nursing facilities, assisted living centers, and mental health facilities.
Core Business: Sabra focuses on acquiring, owning, and financing real estate assets in the healthcare sector. The company’s business model involves leasing properties to healthcare operators, which ensures a steady stream of income. This strategic approach allows Sabra to leverage the growing demand for quality healthcare facilities across the nation.
Recent Achievements: Sabra has recently expanded its portfolio by acquiring several high-quality healthcare properties. These acquisitions are part of Sabra's ongoing strategy to enhance its property mix and geographical presence, positioning the company for long-term growth in the healthcare real estate market.
Current Projects: The company is actively involved in several development and renovation projects aimed at upgrading their existing facilities and supporting their tenants in delivering top-notch healthcare services. These projects are expected to improve operational efficiencies and the overall value of their property portfolio.
Financial Condition: Sabra continues to demonstrate financial stability with a strong balance sheet. The company’s revenue is primarily derived from leasing agreements, providing a reliable income stream. Sabra's prudent financial management and selective investment in high-quality assets contribute to its robust financial condition.
Partnerships: Sabra collaborates with a wide range of healthcare operators, from small local providers to large national chains. These partnerships are crucial for maintaining and enhancing the quality and accessibility of healthcare services across its properties.
Products: Sabra’s offerings include long-term leases on various types of healthcare facilities. These properties are designed to meet the specific needs of different healthcare sectors, ensuring that tenants have the necessary infrastructure to provide excellent care to their patients.
Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced the release date for its 2023 first quarter earnings on May 3, 2023, after trading closes. A conference call will follow on May 4 at 10:00 a.m. PT, allowing investors to discuss the results. U.S. participants can dial in at 888-880-4448, while international participants can reach 646-960-0572, using conference ID 1382596. The event will be webcasted and available for replay on Sabra's website. As a self-managed REIT, Sabra invests in healthcare-related real estate across the U.S. and Canada.
Sabra Health Care REIT (Nasdaq: SBRA) reported a net loss of $(0.37 per diluted share for Q4 2022, alongside FFO of $0.25 and normalized FFO of $0.37. The company transitioned a 24-property portfolio to The Ensign Group and Avamere, generating $34.5 million in initial annual rent. They also acquired an 85% interest in three Canadian senior housing communities for $52.1 million with a 7.6% yield. Seven skilled nursing facilities were disposed of, yielding $25.9 million in gross proceeds. As of December 31, 2022, liquidity stood at $852.3 million. The Board declared a quarterly cash dividend of $0.30 per share, payable on February 28, 2023.
Sabra Health Care REIT (SBRA) announced that CEO Rick Matros will present at the WISE Forum on February 28, 2023, in Rancho Santa Fe, California. Other attendees include Chief Investment Officer Talya Nevo-Hacohen and Executive VP of Investments Darrin Smith. The company is also participating in the NIC Spring Conference from March 1-3, 2023, in San Diego, California, with the same executives attending. Additionally, they will take part in Citi's Global Property CEO Conference from March 5-8, 2023, in Hollywood, Florida. Sabra operates as a self-administered and self-managed REIT focused on healthcare real estate across the U.S. and Canada.
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has announced gross proceeds of approximately
Sabra Health Care REIT, Inc. (NASDAQ: SBRA) will release its 2022 fourth quarter earnings on February 21, 2023, after trading closes. A conference call to discuss the results is scheduled for February 22 at 10:00 a.m. Pacific Time, with U.S. participants using the number 888-880-4448. A quarterly cash dividend of $0.30 per share has been declared, payable on February 28, 2023, for shareholders of record by February 13. Visit www.sabrahealth.com for more details.
Sabra Health Care REIT, Inc. (NASDAQ: SBRA) has announced the tax treatment for its 2022 cash distributions. The total distribution per share is $1.20, which includes $0.87 categorized as ordinary dividends. The dividends consist of $0.22 as non-qualified and $0.08 as qualified dividends. Shareholders need to hold their shares for at least 45 days for dividends to qualify under Section 199A. The company also reported amounts for applicable partnership interests as $0.00. Investors are advised to consult tax advisors regarding the tax implications of these distributions.
Sabra Health Care REIT (NASDAQ: SBRA) will participate in the ASHA’s 2023 Annual Meeting from January 23-25, 2023, at The Westin Kierland in Scottsdale, Arizona. Representing the company will be Talya Nevo-Hacohen, Chief Investment Officer, Darrin Smith, Executive Vice President of Investments, and Eliza Gozar, Senior Vice President of Investments. This event highlights Sabra's commitment to the healthcare real estate sector across the U.S. and Canada.
Sabra Health Care REIT (NASDAQ: SBRA) has amended its credit facility to enhance its debt maturity profile. Key highlights include a $1.0 billion unsecured revolving credit facility maturing in January 2027 with extension options, a $430 million unsecured term loan maturing in January 2028, and a $150 million CAD term loan (~$110 million USD) also maturing in January 2028. The pricing remains consistent with previous terms, linked to adjusted SOFR/CDOR, and an accordion option allows for potential capacity increase to $2.75 billion.
Sabra Health Care REIT (NASDAQ: SBRA) announced its participation in two upcoming virtual conferences. On January 9-10, 2023, Rick Matros (CEO), Michael Costa (CFO), and Talya Nevo-Hacohen (CIO) will represent the company at the Capital One Securities 3rd Annual REIT Conference. Following this, on January 19, 2023, they, along with Darrin Smith (EVP of Investments) and Lukas Hartwich (SVP of Finance), will participate in Stifel's 2023 Seniors Housing and Healthcare Real Estate Conference. These events highlight Sabra's ongoing commitment to the healthcare real estate sector.
Sabra Health Care REIT (SBRA) reported a net loss of $0.22 per diluted share for Q3 2022, with FFO of $0.28 and AFFO of $0.34. Notably, Sabra will transition its 24-property portfolio from North American Health Care to Ensign and Avamere, generating an initial annual rent of $34.5 million. The company is on track to close asset sales generating over $200 million by year-end. As of September 30, 2022, liquidity stood at $887.7 million. A quarterly dividend of $0.30 per share was declared for November 30, 2022.
FAQ
What is the current stock price of Sabra Healthcare REIT (SBRA)?
What is the market cap of Sabra Healthcare REIT (SBRA)?
What is Sabra Healthcare REIT, Inc.?
What types of properties does Sabra own?
How does Sabra generate revenue?
Where does Sabra conduct its operations?
What recent achievements has Sabra made?
What is the financial condition of Sabra?
Who are Sabra's tenants?
What is unique about Sabra's business model?
What partnerships does Sabra have?
What current projects is Sabra involved in?
